Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan's China Airlines, Boeing ink deal for 14 777X jets
05/09/2025 06:19 PM - Society
Chiayi man sentenced to 14.5 year for killing neighbor over noise dispute
05/09/2025 06:17 PM - Business
TSMC reports record monthly revenue in April
05/09/2025 05:34 PM - Business
U.S. dollar closes higher on Taipei forex market
05/09/2025 04:13 PM - Politics
Taiwan medical groups urge WHO to invite Taiwan to WHA as observer
05/09/2025 03:12 PM